On September 13 and 14, the IX International Symposium on Translational Oncology took place, and RISC’s commercial executives were present, representing RISC and Nvidia. The event brought together renowned researchers to discuss advances in translational medicine and clinical research, with a focus on the future of oncology, especially precision medicine.
The Institute of Education and Research (IEP) of the Barretos Cancer Hospital plays a crucial role in this progress, through its initiatives in molecular oncology and clinical research.
Artificial intelligence (AI) and information technology (IT) have been fundamental in healthcare, accelerating data processing and improving diagnostics, in addition to personalizing treatments. RISC is proud to support discussions of great importance to healthcare and technology.
Related Posts
